Artemis Medicare Services enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
4,410————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
33.433.441.614.622.9
6.06.05.96.34.5
227227246254242
4,610————
193193204239219
₹291.20————
1,1681,1681,089708649
19.4%19.4%22.6%35.8%37.2%
0.05×————
4.14×————
22.68×————
30.01×————
170.73×————
Reference items — trailing FY values
1,1141,081937879737
20318815213393.9
15414010792.462.9
—132146109127
27.027.052.536.3−19.3
—21.046.928.5−23.6
—10593.272.6146
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ARTEMISMED₹278.60

Artemis Medicare Services Limited

· Pharma & Health
₹ CrorePeersINDRAMEDCOSHALBYGKSLGPTHEALTHLOTUSEYEDRAGARWQKMCSHILKOVAIMcap ₹4,410 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————4,410.4
- Cash, Equiv & ST Investments22.914.641.633.433.4
+ Minority Interest4.56.35.96.06.0
+ Total Debt241.5253.6245.8226.9226.9
Enterprise Value————4,609.8
Net Debt (memo)218.7239.0204.2193.5193.5
EV per Share————291.20
Total Capital649.2708.21,089.41,167.51,167.5
Total Debt/Total Capital37.2035.8022.5719.4319.43
Total Debt/EV————0.05
EV/Sales————4.14
EV/EBITDA————22.68
EV/EBIT————30.01
EV/Free Cash Flow————170.73
Reference Items — Trailing FY Values
Sales737.4878.6936.91,081.21,113.6
EBITDA93.9132.7151.8188.2203.2
EBIT62.992.4106.6140.1153.6
Operating Cash Flow127.2108.9145.6131.9—
Free Cash Flow-19.336.352.527.027.0
FCFF (free cash flow to the firm)-23.628.546.921.0—
Capital Expenditure146.572.693.2104.9—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.